BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19563008)

  • 1. [Treatment strategy of pituitary invasive prolactinomas].
    Wu ZB; Yu CJ
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):123-7. PubMed ID: 19563008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up.
    Wu ZB; Yu CJ; Su ZP; Zhuge QC; Wu JS; Zheng WM
    J Neurosurg; 2006 Jan; 104(1):54-61. PubMed ID: 16509147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up].
    Zhang HW; Yu CJ; Sun W; Yang J; Yan CX; Cun EH
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(22):1555-7. PubMed ID: 17359664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
    Wu ZB; Su ZP; Wu JS; Zheng WM; Zhuge QC; Zhong M
    Pituitary; 2008; 11(1):63-70. PubMed ID: 17917811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma Knife surgery for invasive pituitary macroadenoma.
    Kim M; Paeng S; Pyo S; Jeong Y; Lee S; Jung Y
    J Neurosurg; 2006 Dec; 105 Suppl():26-30. PubMed ID: 18503326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma knife radiosurgery for pituitary adenomas: usefulness of combined transsphenoidal and gamma knife radiosurgery for adenomas invading the cavernous sinus.
    Ikeda H; Jokura H; Yoshimoto T
    Radiat Oncol Investig; 1998; 6(1):26-34. PubMed ID: 9503487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists.
    Kars M; Pereira AM; Smit JW; Romijn JA
    Eur J Intern Med; 2009 Jul; 20(4):387-93. PubMed ID: 19524180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.
    Pamir MN; Kiliç T; Belirgen M; Abacioğlu U; Karabekiroğlu N
    Neurosurgery; 2007 Aug; 61(2):270-80; discussion 280. PubMed ID: 17762739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of extensively invasive (giant) prolactinomas with bromocriptine.
    Grebe SK; Delahunt JW; Feek CM
    N Z Med J; 1992 Apr; 105(931):129-31. PubMed ID: 1560924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery for metastatic tumors in the pituitary gland and the cavernous sinus.
    Mori Y; Kobayashi T; Shibamoto Y
    J Neurosurg; 2006 Dec; 105 Suppl():37-42. PubMed ID: 18503328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transsphenoidal microsurgical results of non-invasive prolactinomas].
    Xu ZQ; Su CB; Ren ZY; Wang RZ; Yang Y; Ma WB; Li YN; Xing B; Lian W; Yang Z
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(4):293-5. PubMed ID: 18683769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between invasive pituitary adenomas and cavernus sinus and cariod artery and surgical outcomes].
    Ren ZY; Yang Y; Su CB; Wang RZ; Tao W; Ma WB; Li YN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):13-7. PubMed ID: 15782485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant invasive prolactinoma: a case report and review of nine further cases.
    Davis JR; Sheppard MC; Heath DA
    Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings.
    Vieira JO; Cukiert A; Liberman B
    Surg Neurol; 2006 Feb; 65(2):130-5; discussion 135. PubMed ID: 16427401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant prolactinomas: clinical management and long-term follow up.
    Shrivastava RK; Arginteanu MS; King WA; Post KD
    J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of invasive pituitary macroadenoma in 56 patients within a duration of 5 years.
    Chang CZ; Huang YH; Howng SL
    Kaohsiung J Med Sci; 2000 Jul; 16(7):339-44. PubMed ID: 11079292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
    Höfle G; Gasser R; Mohsenipour I; Finkenstedt G
    Exp Clin Endocrinol Diabetes; 1998; 106(3):211-6. PubMed ID: 9710362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
    Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
    No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
    Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
    Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.